VERACYTE, INC. Deferred Tax Assets, Valuation Allowance, Noncurrent
VERACYTE, INC. (VCYT) had Deferred Tax Assets, Valuation Allowance, Noncurrent of $51.66 million as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsValuationAllowanceNoncurrent · last filed 2018-02-27
- 2017-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $51.66M.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $65.97M.
- 2015-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $55.10M.
- 2014-12-31: Deferred Tax Assets, Valuation Allowance, Noncurrent $43.44M; Deferred Tax Assets, Valuation Allowance, Noncurrent as first filed $41.13M.
| Period end | Deferred Tax Assets, Valuation Allowance, Noncurrent | Deferred Tax Assets, Valuation Allowance, Noncurrent as first filed |
|---|---|---|
| 2017-12-31 | $51.66M 10-K · filed 2018-02-27 | |
| 2016-12-31 | $65.97M 10-K · filed 2018-02-27 | |
| 2015-12-31 | $55.10M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $43.44M 10-K · filed 2017-03-01 | $41.13M 10-K · filed 2015-03-25 |
| 2013-12-31 | $32.82M 10-K · filed 2016-03-14 | $31.22M 10-K · filed 2014-03-20 |
| 2012-12-31 | $23.62M 10-K · filed 2015-03-25 | |
| 2011-12-31 | $17.47M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |